Search Results - "Tong, Huaxiang"

Refine Results
  1. 1

    Regulation of Fatty Acid Synthesis by Farnesyl Pyrophosphate by Murthy, Shubha, Tong, Huaxiang, Hohl, Raymond J.

    Published in The Journal of biological chemistry (23-12-2005)
    “…Fatty acid biosynthesis is transcriptionally regulated by liver X receptor (LXR) and its gene target, sterol regulatory element binding protein-1c (SREBP-1c)…”
    Get full text
    Journal Article
  2. 2

    Quantitative Determination of Geranyl Diphosphate Levels in Cultured Human Cells by Holstein, Sarah A, Tong, Huaxiang, Kuder, Craig H, Hohl, Raymond J

    Published in Lipids (01-11-2009)
    “…Geranyl diphosphate (GPP), a 10-carbon isoprenoid, is a key intermediate in the isoprenoid biosynthetic pathway. This pathway, in addition to leading to sterol…”
    Get full text
    Journal Article
  3. 3

    Olefin Isomers of a Triazole Bisphosphonate Synergistically Inhibit Geranylgeranyl Diphosphate Synthase by Allen, Cheryl, Kortagere, Sandhya, Tong, Huaxiang, Matthiesen, Robert A, Metzger, Joseph I, Wiemer, David F, Holstein, Sarah A

    Published in Molecular pharmacology (01-03-2017)
    “…The isoprenoid donor for protein geranylgeranylation reactions, geranylgeranyl diphosphate (GGDP), is the product of the enzyme GGDP synthase (GGDPS) that…”
    Get more information
    Journal Article
  4. 4

    Effects of selective inhibitors of the isoprenoid biosynthetic pathway on androgen‐dependent and independent prostate cancer cells (842.6) by Reilly, Jacqueline, Zhou, Xiang, Tong, Huaxiang, Wiemer, David, Hohl, Raymond

    Published in The FASEB journal (01-04-2014)
    “…The isoprenoid biosynthetic pathway (IBP) provides substrates, such as geranylgeranyl diphosphate (GGDP), which are used to post‐translationally modify…”
    Get full text
    Journal Article
  5. 5

    Synergistic Inhibition of Geranylgeranyl Diphosphate Synthase By a Mixture of Olefin Stereoisomers by Allen, Cheryl, Metzger, Joseph I., Wills, Veronica S., Tong, Huaxiang, Kortagere, Sandhya, Wiemer, David F., Holstein, Sarah A.

    Published in Blood (02-12-2016)
    “…The production of monoclonal protein (MP) by malignant plasma cells is a hallmark of multiple myeloma (MM). We have previously demonstrated that targeting the…”
    Get full text
    Journal Article
  6. 6

    Geranylgeranyl diphosphate depletion inhibits breast cancer cell migration by Dudakovic, Amel, Tong, Huaxiang, Hohl, Raymond J.

    Published in Investigational new drugs (01-10-2011)
    “…Summary The objective of this study was to determine whether geranylgeranyl diphosphate synthase inhibition, and therefore geranylgeranyl diphosphate…”
    Get full text
    Journal Article
  7. 7

    Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase by Zhou, Xiang, Ferree, Sarah D., Wills, Veronica S., Born, Ella J., Tong, Huaxiang, Wiemer, David F., Holstein, Sarah A.

    Published in Bioorganic & medicinal chemistry (01-05-2014)
    “…When inhibitors of enzymes that utilize isoprenoid pyrophosphates are based on the natural substrates, a significant challenge can be to achieve selective…”
    Get full text
    Journal Article
  8. 8

    Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells by Dykstra, Kaitlyn M, Allen, Cheryl, Born, Ella J, Tong, Huaxiang, Holstein, Sarah A

    Published in Oncotarget (08-12-2015)
    “…Multiple myeloma (MM) is characterized by the production of monoclonal protein (MP). We have shown previously that disruption of the isoprenoid biosynthetic…”
    Get full text
    Journal Article
  9. 9

    Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasis by Reilly, Jacqueline E., Neighbors, Jeffrey D., Tong, Huaxiang, Henry, Michael D., Hohl, Raymond J.

    Published in Clinical & experimental metastasis (01-08-2015)
    “…The isoprenoid biosynthetic pathway (IBP) is critical for providing substrates for the post-translational modification of proteins key in regulating malignant…”
    Get full text
    Journal Article
  10. 10

    Quantitative determination of isopentenyl diphosphate in cultured mammalian cells by Tong, Huaxiang, Kuder, Craig H., Wasko, Brian M., Hohl, Raymond J.

    Published in Analytical biochemistry (01-02-2013)
    “…Isopentenyl diphosphate (IPP), an intermediate of the isoprenoid biosynthetic pathway (IBP), has several important biological functions, yet a method to…”
    Get full text
    Journal Article
  11. 11

    Dissecting The Effects Of Isoprenoid Pathway Inhibition On Hemostasis and Thrombosis: Differential Effects Of Atorvastatin and Digeranyl Bisphosphonate In Hypercholesterolemic Mice by Bhasin, Neha, Stevens, Jeff, Niki, Masaru, Tong, Huaxiang, Kuder, Craig, Hohl, Raymond J., Lentz, Steven R

    Published in Blood (15-11-2013)
    “…Statins inhibit HMG-CoA reductase, leading to decreased production of cholesterol and isoprenoid metabolites. There is growing evidence that statins have…”
    Get full text
    Journal Article
  12. 12

    Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase by Wiemer, Andrew J., Tong, Huaxiang, Swanson, Kelly M., Hohl, Raymond J.

    “…A primary cellular target of the clinical nitrogenous bisphosphonates is the isoprenoid biosynthetic pathway. Specifically these drugs inhibit the enzyme…”
    Get full text
    Journal Article
  13. 13

    In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors by Reilly, Jacqueline E., Zhou, Xiang, Tong, Huaxiang, Kuder, Craig H., Wiemer, David F., Hohl, Raymond J.

    Published in Biochemical pharmacology (15-07-2015)
    “…A small set of isoprenoid bisphosphonates ethers has been tested in the K562 chronic myelogenous leukemia cell line to determine their impact on isoprenoid…”
    Get full text
    Journal Article
  14. 14

    Development of selective inhibitors of the isoprenoid biosynthetic pathway and their effects on human‐derived chronic myelogenous leukemia cells by Reilly, Jacqueline E, Zhou, Xiang, Tong, Huaxiang, Wiemer, David, Hohl, Raymond J

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Proteins dependent on post‐translational geranylgeranylation by the isoprenoid biosynthetic pathway (IBP) are key regulators of malignant cell…”
    Get full text
    Journal Article
  15. 15

    Synthesis and Structure-Function Relationship Of Novel Triazole Phosphonates As Inhibitors Of Rab Geranylgeranyl Transferase by Ferree, Sarah D., Zhou, Xiang, Wills, Veronica S., Born, Ella J., Tong, Huaxiang, Wiemer, David F., Holstein, Sarah A

    Published in Blood (15-11-2013)
    “…Multiple myeloma is characterized by the proliferation of malignant plasma cells which secrete large quantities of monoclonal protein (MP). As yet, no…”
    Get full text
    Journal Article
  16. 16

    Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue by Tong, Huaxiang, Wiemer, Andrew J., Neighbors, Jeffrey D., Hohl, Raymond J.

    Published in Analytical biochemistry (15-07-2008)
    “…Farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) are branch point intermediates of isoprenoid biosynthesis. Inhibitors of isoprenoid…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pleiotropic Effects of a Schweinfurthin on Isoprenoid Homeostasis by Holstein, Sarah A., Kuder, Craig H., Tong, Huaxiang, Hohl, Raymond J.

    Published in Lipids (01-10-2011)
    “…The schweinfurthins, a family of natural products derived from the isoprenoid biosynthetic pathway (IBP), have marked growth inhibitory activity. However, the…”
    Get full text
    Journal Article
  19. 19

    2-Amino-3-ketobutyrate-CoA ligase from beef liver mitochondria. Purification and partial sequence by Tong, H, Davis, L

    Published in The Journal of biological chemistry (11-02-1994)
    “…2-Amino-3-ketobutyrate-CoA ligase (EC 2.3.1.29), or aminoacetone synthetase, has been purified by a nine-step procedure from 1.0 kg of beef liver to yield 8.8…”
    Get full text
    Journal Article
  20. 20

    Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells by Holstein, Sarah A, Tong, Huaxiang, Hohl, Raymond J

    Published in Leukemia research (01-03-2010)
    “…Abstract Thalidomide has emerged as an effective agent for treating multiple myeloma, however the precise mechanism of action remains unknown. Agents known to…”
    Get full text
    Journal Article